{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:43:08Z","timestamp":1790109788510,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.thromres.2014.05.016","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T07:31:39Z","timestamp":1400139099000},"page":"264-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis"],"prefix":"10.1016","volume":"134","author":[{"given":"Francesco","family":"Dentali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo Nicola Dario","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Turato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Ambrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2014.05.016_bb0005","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-137-12-200212170-00008","article-title":"Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism","volume":"137","author":"Prandoni","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2014.05.016_bb0010","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jth.12106","article-title":"Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency","volume":"11","author":"Galanaud","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.05.016_bb0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-150-9-200905050-00003","article-title":"AESOPUS Investigators. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial","volume":"150","author":"Prandoni","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2014.05.016_bb0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2008-01-131656","article-title":"Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study","volume":"112","author":"Siragusa","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.05.016_bb0025","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1538-7836.2011.04240.x","article-title":"Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study","volume":"9","author":"Le Gal","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.05.016_bb0030","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1538-7836.2008.02900.x","article-title":"Combination of D-dimer, F1+2 and residualvein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal","volume":"6","author":"Poli","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.05.016_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2141.2011.08578.x","article-title":"Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review","volume":"153","author":"Tan","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.05.016_bb0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000081507","article-title":"Acquired and inherited thrombophilic factors and the risk for residual venous thrombosis","volume":"33","author":"Bank","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.thromres.2014.05.016_bb0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3324\/haematol.12205","article-title":"Thrombophilia as a predictor of persistent residual vein thrombosis","volume":"93","author":"Spiezia","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2014.05.016_bb0050","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1161\/01.CIR.0000148781.87906.C0","article-title":"Factor V Leiden inhibits fibrinolysis in vivo","volume":"110","author":"Parker","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.05.016_bb0055","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1161\/01.ATV.0000244680.14653.9a","article-title":"Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis","volume":"26","author":"Mosnier","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2014.05.016_bb0060","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1160\/TH12-01-0041","volume":"109","author":"Cosmi","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.05.016_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-9560-5-14","article-title":"Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications","volume":"5","author":"Franchini","year":"2007","journal-title":"Thromb J"},{"key":"10.1016\/j.thromres.2014.05.016_bb0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1537-2995.2001.41010056.x","article-title":"Influence of ABO blood groups on primary hemostasis","volume":"41","author":"Moeller","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.thromres.2014.05.016_bb0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1538-7836.2007.02818.x","article-title":"ABO(H) blood groups and vascular disease: a systematic review and meta-analysis","volume":"6","author":"Wu","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.05.016_bb0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-0032-1315758","article-title":"Non-O blood type is the commonest genetic risk factor for VTE: results from a metaanalysis of the literature","volume":"38","author":"Dentali","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2014.05.016_bb0085","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/clinchem\/47.9.1597","article-title":"Laboratory investigation of thrombophilia","volume":"47","author":"Tripodi","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.thromres.2014.05.016_bb0090","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJM200104193441607","article-title":"Genetic susceptibility to venous thrombosis","volume":"344","author":"Seligsohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2014.05.016_bb0095","doi-asserted-by":"crossref","first-page":"W-163","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"for the STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2014.05.016_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/10408363.2012.708647","article-title":"ABO blood group, hypercoagulability, and cardiovascular and cancer risk","volume":"49","author":"Franchini","year":"2012","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.thromres.2014.05.016_bb0105","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.05.016_bb0110","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2141.2000.02113.x","article-title":"Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor","volume":"109","author":"Sarode","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.05.016_bb0115","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1182\/blood-2008-10-165621","article-title":"von Willebrand factor to the rescue","volume":"113","author":"De Meyer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.05.016_bb0120","first-page":"5","article-title":"Sharma KS Fibrinolytic activity and ABO blood types","volume":"11","author":"Bose","year":"1975","journal-title":"DGHS Chron."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2014.05.016_bb0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1538-7836.2009.03394.x","article-title":"Genetics of venous thrombosis","volume":"7","author":"Rosendaal","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.05.016_bb0130","first-page":"164","article-title":"Non-O blood group: an important genetic risk factor for venous thromboembolism","volume":"11","author":"Franchini","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.thromres.2014.05.016_bb0135","first-page":"250","article-title":"ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia","volume":"11","author":"Spiezia","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.thromres.2014.05.016_bb0140","first-page":"713","article-title":"The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients","volume":"90","author":"Cosmi","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2014.05.016_bb0145","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1160\/TH13-06-0488","article-title":"Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study","volume":"110","author":"G\u00e1ndara","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.05.016_bb0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1503\/cmaj.080493","article-title":"Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy","volume":"179","author":"Rodger","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.thromres.2014.05.016_bb0155","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","article-title":"Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model","volume":"121","author":"Eichinger","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.05.016_bb0160","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","article-title":"Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)","volume":"10","author":"Tosetto","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.05.016_bb0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.thromres.2010.01.017","article-title":"Influence of anticoagulant therapy with vitamin K antagonists on plasma levels of coagulation factor VIII","volume":"126","author":"Passamonti","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.05.016_bb0170","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/s-0038-1656061","article-title":"High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction","volume":"77","author":"O'Donnell","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.05.016_bb0175","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ejim.2007.06.036","article-title":"Relation between hemostetic parameters and prognostic\/predictive factors in breast cancer","volume":"19","author":"Yigit","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.thromres.2014.05.016_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2003-38897","article-title":"Hemostasis during normal pregnancy and puerperium","volume":"29","author":"Hellgren","year":"2003","journal-title":"Sem Thromb Haemost"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814002813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814002813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T12:38:26Z","timestamp":1597840706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814002813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0049384814002813"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.05.016","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}